Answers are grounded in this paper and cite their sources.
Case report demonstrates AI's role in identifying pharmacogenomic errors, suggesting effective exposome integration.
This preprint presents a two-layer architecture for AI-supported precision medicine, demonstrated through a case report (ASES-2307-002). Layer 1 uses the open-source ClawBio pipeline for reproducible genotype reporting, externally validated through four rounds of peer review (PR #133). Layer 2 introduces the FHH (Health History and Holography Questionnaire), an 8-dimension holonic instrument that operationalizes the exposome for clinical integration. Six pharmacogenomic misclassifications were identified and corrected through systematic raw data revalidation. The architecture is grounded in holonic epistemology (Holomedicina, Carmona Aguirre, 2014). Target journal: Journal of Personalized Medicine (MDPI).
No takes yet. Share an insight, caveat, or question.
Samuel Carmona Aguirre (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: